Inventor · disambiguated record
Hon-Wah Man
Also filed as: MAN HON-WAH
129 granted patents·26 pending applications·3,391 citations·filing 1995–2025
99Inventor score
Top patents by PatentIndex Score
155 records- 0199US7893101B2Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereofCELGENE CORP·Filed 2008·Granted Feb 22, 2011·44 cites·15 claims
- 0299US6403613B11-oxo-and 1,3-dioxoisoindolinesFiled 2000·Granted Jun 11, 2002·258 cites·20 claims
- 0399US5874448ASubstituted 2-(2,6 dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing TNFα levelsCELGENE CORP·Filed 1997·Granted Feb 23, 1999·285 cites·23 claims
- 0498US7635700B25-Substituted quinazolinone derivatives and compositions comprising and methods of using the sameCELGENE CORP·Filed 2007·Granted Dec 22, 2009·78 cites·16 claims
- 0598US7427638B2(+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione:, and methods of synthesis and compositions thereofCELGENE CORP·Filed 2005·Granted Sep 23, 2008·53 cites·13 claims
- 0698US7244759B2Isoindoline compounds and methods of making and using the sameCELGENE CORP·Filed 2004·Granted Jul 17, 2007·138 cites·6 claims
- 0798US7091353B2Isoindole-imide compounds, compositions, and uses thereofCELGENE CORP·Filed 2001·Granted Aug 15, 2006·147 cites·15 claims
- 0898US6962940B2(+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereofCELGENE CORP·Filed 2003·Granted Nov 8, 2005·107 cites·23 claims
- 0998US6458810B1Pharmaceutically active isoindoline derivativesMULLER GEORGE·Filed 2000·Granted Oct 1, 2002·281 cites·18 claims
- 1098US6020358ASubstituted phenethylsulfones and method of reducing TNFα levelsCELGENE CORP·Filed 1998·Granted Feb 1, 2000·296 cites·19 claims
- 1198US5955476ASubstituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levelsCELGENE CORP·Filed 1998·Granted Sep 21, 1999·267 cites·23 claims
- 1297US9499514B2Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2015·Granted Nov 22, 2016·28 cites·29 claims
- 1397US9365524B2Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their useSIGNAL PHARM LLC·Filed 2015·Granted Jun 14, 2016·22 cites·36 claims
- 1497US8518972B2Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the sameMAN HON-WAH·Filed 2011·Granted Aug 27, 2013·74 cites·7 claims
- 1597US8455536B2Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dioneMULLER GEORGE W·Filed 2009·Granted Jun 4, 2013·28 cites·56 claims
- 1697US7659302B2Methods of using (+)-2-[1-(3-ethoxy-4 methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dioneCELGENE CORP·Filed 2008·Granted Feb 9, 2010·35 cites·20 claims
- 1797US6011050ASubstituted phenethylsulfones and method of reducing TNFα levelsCELGENE CORP·Filed 1999·Granted Jan 4, 2000·172 cites·16 claims
- 1896US11185543B2Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2020·Granted Nov 30, 2021·5 cites·20 claims
- 1996US9814713B2Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their useSIGNAL PHARM LLC·Filed 2016·Granted Nov 14, 2017·14 cites·21 claims
- 2096US9018243B2Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereofCELGENE CORP·Filed 2013·Granted Apr 28, 2015·13 cites·21 claims
- 2196US8093283B2Solid forms comprising (+)-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisinoline-1,3-dione, compositions thereof, and uses thereofMULLER GEORGE W·Filed 2010·Granted Jan 10, 2012·17 cites·42 claims
- 2296US7820697B2Compositions and method for reducing TNFα levelsCELGENE CORP·Filed 2005·Granted Oct 26, 2010·27 cites·2 claims
- 2396US7659303B2Methods of using (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4- acetylaminoisoindoline-1,3-dioneCELGENE CORP·Filed 2008·Granted Feb 9, 2010·21 cites·14 claims
- 2496US7507759B2Methods of using(+)-2-[1-(3-ethoxy-4methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3,-dioneCELGENE CORP·Filed 2007·Granted Mar 24, 2009·21 cites·11 claims
- 2596US7358272B2Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dioneCELGENE CORP·Filed 2005·Granted Apr 15, 2008·21 cites·17 claims
- 2695US10357489B2Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2018·Granted Jul 23, 2019·20 cites·26 claims
- 2795US9828361B2Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the sameCELGENE CORP·Filed 2016·Granted Nov 28, 2017·12 cites·10 claims
- 2895US8802717B2Methods of treating arthritic conditions using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dioneCELGENE CORP·Filed 2012·Granted Aug 12, 2014·13 cites·22 claims
- 2995US8629173B2Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereofMULLER GEORGE W·Filed 2011·Granted Jan 14, 2014·11 cites·39 claims
- 3095US8153659B24′-O-substituted isoindoline derivatives and compositions comprising and methods of using the sameRUCHELMAN ALEXANDER L·Filed 2008·Granted Apr 10, 2012·30 cites·21 claims
- 3195US8012997B2Isoindole-imide compounds, compositions, and uses thereofCELGENE CORP·Filed 2009·Granted Sep 6, 2011·30 cites·8 claims
- 3295US6667316B1Pharmaceutically active isoindoline derivativesCELGENE CORP·Filed 2000·Granted Dec 23, 2003·88 cites·19 claims
- 3394US9808451B2Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2016·Granted Nov 7, 2017·12 cites·19 claims
- 3494US9724330B2Methods of using (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dioneCELGENE CORP·Filed 2016·Granted Aug 8, 2017·7 cites·33 claims
- 3594US8481568B2Isoindole-imide compounds and compositions comprising and methods of using the sameMULLER GEORGE·Filed 2011·Granted Jul 9, 2013·26 cites·5 claims
- 3694US7576104B2Isoindole-imide compounds, compositions, and uses thereofCELGENE CORP·Filed 2005·Granted Aug 18, 2009·24 cites·14 claims
- 3794US7256210B27-amido-isoindolyl compounds and methods of their useCELGENE CORP·Filed 2005·Granted Aug 14, 2007·24 cites·7 claims
- 3893US10894796B2MK2 inhibitors, synthesis thereof, and intermediates theretoCELGENE CAR LLC·Filed 2018·Granted Jan 19, 2021·8 cites·19 claims
- 3993US9822094B2Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the sameCELGENE CORP·Filed 2016·Granted Nov 21, 2017·9 cites·12 claims
- 4093US8802685B2Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and usesMULLER GEORGE·Filed 2012·Granted Aug 12, 2014·9 cites·61 claims
- 4193US7511072B27-amido-isoindolyl compounds and methods of its useCELGENE CORP·Filed 2007·Granted Mar 31, 2009·16 cites·2 claims
- 4293US6911464B2N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical usesCELGENE CORP·Filed 2004·Granted Jun 28, 2005·41 cites·26 claims
- 4393US6326388B1Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha levelCELGENE CORP·Filed 1999·Granted Dec 4, 2001·115 cites·26 claims
- 4492US10626101B2Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2018·Granted Apr 21, 2020·3 cites·10 claims
- 4592US9968596B2Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2017·Granted May 15, 2018·8 cites·26 claims
- 4692US7034052B27-Amido-isoindolyl compounds and their pharmaceutical usesCELGENE CORP·Filed 2004·Granted Apr 25, 2006·32 cites·13 claims
- 4791US10189808B2Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2017·Granted Jan 29, 2019·10 cites·10 claims
- 4891US10092542B2Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dioneCELGENE CORP·Filed 2017·Granted Oct 9, 2018·4 cites·17 claims
- 4991US9283207B2Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dioneCELGENE CORP·Filed 2014·Granted Mar 15, 2016·7 cites·24 claims
- 5091US9067912B2Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,8-dioneCELGENE CORP·Filed 2014·Granted Jun 30, 2015·5 cites·42 claims
Showing the top 50 of 155 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →